BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Hippocampus
,
Hematopoietic cell
,
Lipitor
,
rs4950928
,
FOXP1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antagonists androgen receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Advances in the computational development of androgen receptor antagonists.
Metabolism-Guided Selective Androgen Receptor Antagonists: Design, Synthesis, and Biological Evaluat…
Structure-property and structure-activity relationships of phenylferrocene derivatives as androgen r…
Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen re…
Development of novel androgen receptor antagonists based on the structure of darolutamide.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hor…
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Cas…
Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Pros…
Contributions to Hypertension With Androgen Deprivation Therapy
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive S…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ